| [1] |
KRAJEWSKI P, POMIANEK T, TRUSZKOWSKI K, et al. Respiratory distress syndrome in preterm infants:possible impact of surfactant application techniques[J]. Ginekol Pol, 2022, 93(9):750-755.
DOI
URL
|
| [2] |
SILVEIRA R C, PANCERI C, MUNÕZ N P, et al. Less invasive surfactant administration versus intubation-surfactant-extubation in the treatment of neonatal respiratory distress syndrome:a systematic review and meta-analyses[J]. J Pediatr(Rio J), 2024, 100(1):8-24.
|
| [3] |
HAIDER S, AZHAR N, ZAHID M, et al. Comparative effectiveness of calfactant and beractant in neonatal respiratory distress syndrome:a systemic review and meta-analysis[J]. Pediatr Pulmonol, 2022, 57(12):2928-2936.
DOI
URL
|
| [4] |
LU Q, YU S, MENG X, et al. MicroRNAs:important regulatory molecules in acute lung injury/acute respiratory distress syndrome[J]. Int J Mol Sci, 2022, 23(10):1-10.
DOI
URL
|
| [5] |
崔云会. 支气管哮喘患儿外周血miR-30a、miR-15b-5p水平与气道炎症、肺功能的关系[J]. 医学理论与实践, 2024, 37(1):19-22.
|
| [6] |
CUI Y, WANG X, LIN F, et al. MiR-29a-3p improves acute lung injury by reducing alveolar epithelial cell PANoptosis[J]. Aging Dis, 2022, 13(3):899-909.
DOI
URL
|
| [7] |
翟斌, 韩梅. 肺炎支原体肺炎患儿血清miR-21、miR-146a表达变化及其与炎症因子的相关性[J]. 检验医学, 2024, 39(8):787-792.
DOI
|
| [8] |
邵肖梅, 叶鸿瑁, 邱小汕. 实用新生儿学[M]. 4版. 北京: 人民卫生出版社, 2011.
|
| [9] |
REYNOLDS P, BUSTANI P, DARBY C, et al. Less-invasive surfactant administration for neonatal respiratory distress syndrome:a consensus guideline[J]. Neonatology, 2021, 118(5):586-592.
DOI
URL
|
| [10] |
YISMAW A E, GELAGAY A A, SISAY M M, et al. Predictors of time to recovery of preterm neonates with respiratory distress syndrome admitted in University of Gondar comprehensive specialized hospital neonatal intensive care unit North West Ethiopia[J]. PLoS One, 2022, 17(10):e0275366-e0275379.
|
| [11] |
MARTUCCI G, ARCADIPANE A, TUZZOLINO F, et al. Identification of a circulating miRNA signature to stratify acute respiratory distress syndrome patients[J]. J Pers Med, 2020, 11(1):1-15.
|
| [12] |
侯雅超, 陈昌国, 韩瑞. MicroRNA在肺小结节鉴别诊断中的研究进展[J]. 转化医学杂志, 2022, 11(4):259-262.
|
| [13] |
PARZIBUT G, HENKET M, MOERMANS C, et al. A blood exosomal miRNA signature in acute respiratory distress syndrome[J]. Front Mol Biosci, 2021, 8(1):1-9.
|
| [14] |
LEE L K, MEDZIKOVIC L, EGHBALI M, et al. The role of microRNAs in acute respiratory distress syndrome and sepsis,from targets to therapies:a narrative review[J]. Anesth Analg, 2020, 131(5):1471-1484.
DOI
URL
|
| [15] |
COSKUNPINAR E, AKCESME B, TAS S K, et al. Investigation of miRNAs that are effective in the pathogenesis of asthma[J]. J Asthma, 2023, 60(12):2145-2152.
DOI
URL
|
| [16] |
NAJAFIPOUR R, MOHAMMADI D, ESTAKI Z, et al. Screening for differentially expressed microRNAs in BALF and blood samples of infected COVID-19 ARDS patients by small RNA deep sequencing[J]. J Clin Lab Anal, 2022, 36(11):1-12.
|
| [17] |
LI P, HAO X, LIU J, et al. MiR-29a-3p regulates autophagy by targeting Akt3-mediated mTOR in SiO2-induced lung fibrosis[J]. Int J Mol Sci, 2023, 24(14):1-11.
DOI
URL
|
| [18] |
ZHANG X, XIE J, SUN H, et al. MiR-29a-3p regulates the epithelial-mesenchymal transition via the SPARC/ERK signaling pathway in human bronchial epithelial cells[J]. Int J Mol Med, 2021, 48(3):171-182.
DOI
URL
|
| [19] |
许花芬, 冯琼, 李春蕾. miR-29a-3p与ELN在早产儿支气管肺发育不良患儿中的表达意义[J]. 重庆医学, 2022, 51(17):2932-2935.
|
| [20] |
余岳芬, 刘振华, 廖海燕, 等. 血清miR-92a和miR-146a表达水平联合肺部超声评分预测ARDS严重程度及预后的价值[J]. 中华危重病急救医学, 2020, 32(10):1231-1235.
|
| [21] |
周燕. 血清微小RNA-146a、细胞间黏附分子-1与急性呼吸窘迫综合征患者病情严重程度和预后的关系[J]. 中国卫生检验杂志, 2022, 32(17):2123-2131.
|
| [22] |
HONG H, FU B, WANG R. Clinical value of serum miR-92 and miR-122 expression level combined with pulmonary ultrasound score in the prognosis of neonatal acute respiratory distress syndrome[J]. J Clin Lab Anal, 2022, 36(7):1-15.
|
| [23] |
LI Q, CHEN Y, LIN L. Value of serum miR-34a and Ang-1 in severity evaluation and prognosis of neonatal respiratory distress syndrome[J]. Emerg Med Int, 2022, 21(1):1-10.
DOI
|